1. Home
  2. DNLI vs SHOO Comparison

DNLI vs SHOO Comparison

Compare DNLI & SHOO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • DNLI
  • SHOO
  • Stock Information
  • Founded
  • DNLI 2013
  • SHOO 1990
  • Country
  • DNLI United States
  • SHOO United States
  • Employees
  • DNLI N/A
  • SHOO N/A
  • Industry
  • DNLI Biotechnology: Biological Products (No Diagnostic Substances)
  • SHOO Shoe Manufacturing
  • Sector
  • DNLI Health Care
  • SHOO Consumer Discretionary
  • Exchange
  • DNLI Nasdaq
  • SHOO Nasdaq
  • Market Cap
  • DNLI 2.1B
  • SHOO 2.0B
  • IPO Year
  • DNLI 2017
  • SHOO 1993
  • Fundamental
  • Price
  • DNLI $15.42
  • SHOO $34.43
  • Analyst Decision
  • DNLI Strong Buy
  • SHOO Buy
  • Analyst Count
  • DNLI 15
  • SHOO 7
  • Target Price
  • DNLI $33.50
  • SHOO $30.33
  • AVG Volume (30 Days)
  • DNLI 2.1M
  • SHOO 1.7M
  • Earning Date
  • DNLI 11-05-2025
  • SHOO 11-06-2025
  • Dividend Yield
  • DNLI N/A
  • SHOO 2.44%
  • EPS Growth
  • DNLI N/A
  • SHOO N/A
  • EPS
  • DNLI N/A
  • SHOO 1.28
  • Revenue
  • DNLI N/A
  • SHOO $2,319,527,000.00
  • Revenue This Year
  • DNLI N/A
  • SHOO $11.57
  • Revenue Next Year
  • DNLI $95,463.19
  • SHOO $10.13
  • P/E Ratio
  • DNLI N/A
  • SHOO $26.99
  • Revenue Growth
  • DNLI N/A
  • SHOO 7.97
  • 52 Week Low
  • DNLI $10.57
  • SHOO $19.05
  • 52 Week High
  • DNLI $33.33
  • SHOO $49.38
  • Technical
  • Relative Strength Index (RSI)
  • DNLI 62.72
  • SHOO 72.02
  • Support Level
  • DNLI $12.58
  • SHOO $32.96
  • Resistance Level
  • DNLI $15.75
  • SHOO $34.01
  • Average True Range (ATR)
  • DNLI 0.68
  • SHOO 1.04
  • MACD
  • DNLI 0.24
  • SHOO 0.02
  • Stochastic Oscillator
  • DNLI 89.59
  • SHOO 87.87

About DNLI Denali Therapeutics Inc.

Denali Therapeutics Inc is a biotechnology company that is engaged in developing and discovering therapeutics to defeat neurodegeneration disease. The company's development programs include the LRRK2 Inhibitor Program, which develops brain penetrant small molecule LRRK2 inhibitor product candidates for Parkinson's disease. Its key products include DNL201, DNL151, DNL747, ATV (Antibody Transport Vehicle), ETV (Enzyme Transport Vehicle), and others.

About SHOO Steven Madden Ltd.

Steven Madden Ltd designs and sells brand-name and private-label footwear and accessories. Its products are geared toward fashion-conscious adults and children. The company sells its products through department stores and other retailers as well as its stores and websites. The company's revenue comes from its operating segments: Wholesale Footwear, Wholesale Accessories or Apparel, Direct-to-Consumer, and Licensing. The wholesale footwear segment accounts for the majority of revenue.

Share on Social Networks: